Dianthus Therapeutics, Inc. - Common Stock (NQ: DNTH )

11.27 +0.09 (+0.81%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2023 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	23,339
Open	11.35
Bid (Size)	10.70 (2)
Ask (Size)	11.36 (1)
Prev. Close	11.18
Today's Range	10.58 - 11.36
52wk Range	9.770 - 13.75
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Antibody Player Dianthus Therapeutics Has Potential Amid Active M&A Landscape in Complement-Focused Firms: Analyst

November 22, 2023

Wedbush initiated coverage on Dianthus Therapeutics Inc (NASDAQ: DNTH), noting its lead program DNTH103 as a well-positioned monoclonal antibody directed against the active form of the

Via Benzinga

Dianthus' Monoclonal Antibody On Promising Pathway To Gaining The Upper Hand - Analyst

September 28, 2023

Raymond James initiated coverage on Dianthus Therapeutics Inc (NASDAQ: DNTH), a recent reverse merger with the old Magenta Therapeutics.

Via Benzinga

Performance

YTD	+2.45%	+2.45%
1 Month	-6.08%	-6.08%
3 Month	+2.45%	+2.45%
6 Month	+2.45%	+2.45%
1 Year	+2.45%	+2.45%

More News

Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023

September 28, 2023

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.